These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 10925169)

  • 1. Dynorphin modulates dopamine D1-receptor mediated turning behavior in 6-hydroxydopamine-lesioned rats.
    van de Witte SV; Groenewegen HJ; Drukarch B; Voorn P
    Neurosci Lett; 2000 Aug; 290(1):37-40. PubMed ID: 10925169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Priming with L-DOPA differently affects dynorphin and substance P mRNA levels in the striatum of 6-hydroxydopamine-lesioned rats after challenge with dopamine D1-receptor agonist.
    van de Witte SV; Drukarch B; Stoof JC; Voorn P
    Brain Res Mol Brain Res; 1998 Oct; 61(1-2):219-23. PubMed ID: 9795227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MK-801 alters the effects of priming with L-DOPA on dopamine D1 receptor-induced changes in neuropeptide mRNA levels in the rat striatal output neurons.
    Van De Witte SV; Groenewegen HJ; Voorn P
    Synapse; 2002 Jan; 43(1):1-11. PubMed ID: 11746728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased striatal expression of glutamate decarboxylase 67 after priming of 6-hydroxydopamine-lesioned rats.
    Consolo S; Morelli M; Rimoldi M; Giorgi S; Di Chiara G
    Neuroscience; 1999; 89(4):1183-7. PubMed ID: 10362306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of movement in hemiparkinsonian rats influences the modifications induced by dopamine agonists in striatal efferent dynorphinergic neurons.
    Frau L; Morelli M; Simola N
    Exp Neurol; 2013 Sep; 247():663-72. PubMed ID: 23499830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D1 priming enhances both D1- and D2-mediated rotational behavior and striatal Fos expression in 6-hydroxydopamine lesioned rats.
    Pollack AE; Thomas LI
    Pharmacol Biochem Behav; 2010 Jan; 94(3):346-51. PubMed ID: 19800912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine D1 receptor modulation of glutamate receptor messenger RNA levels in the neocortex and neostriatum of unilaterally 6-hydroxydopamine-lesioned rats.
    Rodríguez-Puertas R; Herrera-Marschitz M; Koistinaho J; Hökfelt T
    Neuroscience; 1999 Mar; 89(3):781-97. PubMed ID: 10199613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopaminergic modulation of striatal neuropeptides: differential effects of D1 and D2 receptor stimulation on somatostatin, neuropeptide Y, neurotensin, dynorphin and enkephalin.
    Engber TM; Boldry RC; Kuo S; Chase TN
    Brain Res; 1992 May; 581(2):261-8. PubMed ID: 1356580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of MK 801 on priming of D1-dependent contralateral turning and its relationship to c-fos expression in the rat caudate-putamen.
    Morelli M; Fenu S; Carta A; Di Chiara G
    Behav Brain Res; 1996 Sep; 79(1-2):93-100. PubMed ID: 8883820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the D1-dopamine agonists SKF-38393 and A-68930 in neonatal 6-hydroxydopamine-lesioned rats: behavioral effects and induction of c-fos-like immunoreactivity.
    Johnson KB; Criswell HE; Jensen KF; Simson PE; Mueller RA; Breese GR
    J Pharmacol Exp Ther; 1992 Aug; 262(2):855-65. PubMed ID: 1354257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of synergism between caffeine and SKF 38393 on rotational behavior in 6-hydroxydopamine-denervated rats.
    Casas M; Prat G; Rubio A; Barbanoj M; Jané F
    Eur J Pharmacol; 2000 May; 396(2-3):93-9. PubMed ID: 10822061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine-dependent behavioural stimulation by non-peptide delta opioids BW 373U86 and SNC 80: 3. Facilitation of D1 and D2 responses in unilaterally 6-hydroxydopamine-lesioned rats.
    Pinna A; Di Chiara G
    Behav Pharmacol; 1998 Feb; 9(1):15-21. PubMed ID: 9832944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of dopamine D-1 and D-2 receptor subtype agonists on nigrostriatal opioid dynorphin and enkephalin immunostaining in 6-hydroxydopamine lesioned rats.
    Jiang HK; Wang JY
    Chin J Physiol; 1991; 34(4):413-25. PubMed ID: 1687937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The atypical dopamine D1 receptor agonist SKF 83959 induces striatal Fos expression in rats.
    Wirtshafter D; Osborn CV
    Eur J Pharmacol; 2005 Dec; 528(1-3):88-94. PubMed ID: 16324697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential modulation of striatonigral dynorphin and enkephalin by dopamine receptor subtypes.
    Jiang HK; McGinty JF; Hong JS
    Brain Res; 1990 Jan; 507(1):57-64. PubMed ID: 1967976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subchronic intermittent caffeine administration to unilaterally 6-hydroxydopamine-lesioned rats sensitizes turning behaviour in response to dopamine D(1) but not D(2) receptor agonists.
    Cauli O; Pinna A; Morelli M
    Behav Pharmacol; 2005 Dec; 16(8):621-6. PubMed ID: 16286813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The selective mGlu(5) receptor agonist CHPG inhibits quinpirole-induced turning in 6-hydroxydopamine-lesioned rats and modulates the binding characteristics of dopamine D(2) receptors in the rat striatum: interactions with adenosine A(2a) receptors.
    Popoli P; Pèzzola A; Torvinen M; Reggio R; Pintor A; Scarchilli L; Fuxe K; Ferré S
    Neuropsychopharmacology; 2001 Oct; 25(4):505-13. PubMed ID: 11557164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of striatal acetylcholine on dopamine D1 receptor agonist-induced turning behavior in 6-hydroxydopamine lesioned rats: a microdialysis-behavioral study.
    Fenu S; Acquas E; Di Chiara G
    Neurol Sci; 2001 Feb; 22(1):63-4. PubMed ID: 11487203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeated treatments with the D
    Park HJ; Zhao TT; Park KH; Lee MK
    Behav Brain Res; 2019 Jul; 367():166-175. PubMed ID: 30930179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.